EVO VIVA ICL

EVO VIVA ICL is an Extended Depth of Focus phakic intraocular lens that improves distance and intermediate vision. The surgeon implants this lens inside the eye without removing corneal tissue. As a result, the procedure preserves the natural cornea while delivering clear and stable vision.

WHAT EVO VIVA ICL CORRECTS

EVO VIVA ICL corrects moderate to high nearsightedness and astigmatism while extending focus for distance and intermediate activities. Patients often see more clearly when driving, using digital devices, or performing daily tasks. However, patients still need reading glasses for near work.

HOW THE PROCEDURE WORKS

The ophthalmologist performs a detailed eye evaluation to confirm eligibility. During the procedure, the surgeon creates a small corneal incision and inserts the foldable lens into the eye. The lens rests behind the iris and in front of the natural lens. This approach preserves corneal structure and allows reversibility when medically indicated.

WHO MAY BENEFIT

EVO VIVA ICL suits patients who are not ideal candidates for LASIK or PRK. It also serves patients who prefer a cornea-preserving option. This procedure may benefit the following individuals.

1. Patients with moderate to high myopia
2. Individuals with thin or borderline corneas
3. Patients seeking improved distance and intermediate vision
4. Adults with stable prescriptions
5. Patients who prefer a reversible procedure

RECOVERY AND EXPECTED OUTCOMES

Patients often notice visual improvement soon after surgery. Most patients resume normal activities within a short recovery period. Vision continues to stabilize over time, and scheduled follow-up visits ensure proper healing. Reading glasses remain necessary for near tasks.

SAFETY AND CLINICAL CONSIDERATIONS

The EVO VIVA ICL includes ultraviolet protection and a central port that supports natural fluid flow. Proper screening ensures adequate eye anatomy and stable eye pressure. Risks include infection, inflammation, pressure changes, and lens-related complications. The ophthalmologist determines final suitability after complete diagnostics.